Latest

Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆

Menu

Home

Biotechnology Clinical Trials Industry MedTech Pharmaceutical Regulatory Affairs

Registers Tools Regulatory News FDA Approvals Tracker FDA Recall Tracker EMA Approvals Tracker Drug Shortages Tracker EU Medicine Shortages Germany Medicine Shortages EPA Manufacturing Compliance Pharma Events Ireland Layoffs Tracker Clinical Trials Ireland Clinical Trials Europe Clinical Trials UK Clinical Trials USA Clinical Trials India Clinical Trials China Irish Medicines Database Drug Directory Molecule Target Lookup PDF Tools Suite Company Directory Irish Salary Guide EU Salary Guide UK Salary Guide US Salary Guide Careers & Prep Education Knowledge Hub About Write for Us

Search Results

Found 4 results for "neurology" across articles, medicines, trials, companies and the glossary

SK Biopharmaceuticals Acquires Epilepsy Candidate Opakalim in 795 Million Dollar Deal

SK Biopharmaceuticals Acquires Epilepsy Candidate Opakalim in 795 Million Dollar Deal

SK Biopharmaceuticals has secured the global licensing rights to Biohaven's selective Kv7 channel activator opakalim (BHV-7000) in a deal valued at up to $795 million.

A Biotech Buying Frenzy: Inside the H1 2026 Pharma M&A Surge

A Biotech Buying Frenzy: Inside the H1 2026 Pharma M&A Surge

An in-depth analysis of the massive wave of pharmaceutical mergers and acquisitions in the first half of 2026, driven by patent cliffs, pipeline replenishment, and high-growth therapeutic areas.

LinkedIn for Medical Science Liaisons (MSLs): The Complete Guide to Showcasing Scientific Expertise Without Violating Compliance

LinkedIn for Medical Science Liaisons (MSLs): The Complete Guide to Showcasing Scientific Expertise Without Violating Compliance

A step-by-step compliance-safe LinkedIn guide exclusively for Medical Science Liaisons. Covers profile optimisation, what to post, what never to post, KOL engagement, off-label rules, digital medical affairs strategy, and how to build scientific credibility on LinkedIn without breaching pharmaceutical regulatory guidelines.

Eisai Allocates £48M to UK Cold-Chain Pharma Packaging Hub

Eisai Allocates £48M to UK Cold-Chain Pharma Packaging Hub

Japanese pharmaceutical company Eisai announces a £48 million investment at its Hatfield, UK site to establish advanced cold-chain supply and packaging capabilities, supported by the Life Sciences Innovative Manufacturing Fund.